Exp Clin Endocrinol Diabetes 2003; 111(5): 288-293
DOI: 10.1055/s-2003-41287
Case Report

J. A. Barth Verlag in Georg Thieme Verlag Stuttgart · New York

Lupus-like Panniculitis in a Patient with Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED)

M. Füchtenbusch[*] 1 , A. Vogel[*] 2 , P. Achenbach 1 , M. Gummer 3 , A. G. Ziegler 1 , E. Albert 4 , E. Standl 1 , M. P. Manns 2
  • 1Department of Endocrinology, Diabetology and Gastroenterology, Academic Hospital München-Schwabing, Munich, Germany
  • 2Department of Gastroenterology, Hepatology and Endocrinology, Hanover Medical School, Hanover, Germany
  • 3Department of Dermatology, Academic Hospital München-Schwabing, Munich, Germany
  • 4National Reference Laboratory for Tissue Typing, University of Munich, Germany
Further Information

Publication History

Received: September 20, 2002 First decision: October 20, 2002

Accepted: January 10, 2003

Publication Date:
02 September 2003 (online)

Abstract

Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) is a rare autosomal recessive disorder, characterised by a loss of self-tolerance to endocrine tissues, chronic candidiasis and ectodermal disorders. APECED is associated with mutations of a single gene, designated autoimmune regulator (AIRE). We describe a 31-year-old APECED patient with non-traumatic, cutaneous ulcers on both forearms with features of a lupus-like panniculitis. On admission to the ICU in September 2001, the patient suffered from a ketoacidotic, hyperglycemic coma and adrenal crisis due to an Enterobacter-cloacae sepsis, originating from multiple, necrotising deep cutaneous ulcers. These ulcers spontaneously developed on both forearms, some of which were just emerging, full blown or healing with scars. Histological examination showed signs of a scarring panniculitis and vasculitis. Immunohistochemistry and direct immunofluorescence with characterisation of immunoglobulin and complement-factor binding pattern revealed features of a lupus-like panniculitis. Sequence analysis of all 14 exons of the AIRE gene revealed a R257 X mutation in exon 6 resulting in a nonsense mutation at codon 257 confirming the diagnosis of APECED. Oral treatment with 60 mg/day corticosteroids for two weeks led to complete resolution of all ulcers. In conclusion, mutations in the AIRE gene may provide the genetic background against which additional factors can initiate an autoimmune process. Here, autoimmune panniculitis appears to be an associated feature of the APECED syndrome. Our findings support the use of immunosuppressive therapy for autoimmune disease components of the APECED syndrome.

References

  • 1 Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.  N Engl J Med. 1990;  322 1829-1836
  • 2 Betterle C, Greggio N A, Volpato M. Clinical review 93: Autoimmune polyglandular syndrome type 1.  J Clin Endocrinol Metab. 1998;  83 1049-1055
  • 3 Consortium T F-GA. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains. The Finnish-German APECED Consortium. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy.  Nat Genet. 1997;  17 399-403
  • 4 Dalekos G N, Wedemeyer H, Obermayer-Straub P, Kayser A, Barut A, Frank H, Manns M P. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment.  J Hepatol. 1999;  30 366-375
  • 5 Halonen M, Eskelin P, Myhre A G, Perheentupa J, Husebye E S, Kampe O, Rorsman F, Peltonen L, Ulmanen I, Partanen J. AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype.  J Clin Endocrinol Metab. 2002;  87 2568-2574
  • 6 Kumar P G, Laloraya M, Wang C Y, Ruan O G, Davoodi-Semiromi A, Kao K J, She J X. The autoimmune regulator (AIRE) is a DNA-binding protein.  J Biol Chem. 2001;  276 41357-41364
  • 7 Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Büschenfelde K H. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen.  Lancet. 1987;  I 292-294
  • 8 Meloni A, Perniola R, Faa V, Corvaglia E, Cao A, Rosatelli M C. Delineation of the molecular defects in the AIRE gene in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients from Southern Italy.  J Clin Endocrinol Metab. 2002;  87 841-846
  • 9 Nagamine K, Peterson P, Scott H S, Kudoh J, Minoshima S, Heino M, Krohn K J, Lalioti M D, Mullis P E, Antonarakis S E, Kawasaki K, Asakawa S, Ito F, Shimizu N. Positional cloning of the APECED gene.  Nat Genet. 1997;  17 393-398
  • 10 Obermayer-Straub P, Perheentupa J, Braun S, Kayser A, Barut A, Loges S, Harms A, Dalekos G, Strassburg C P, Manns M P. Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.  Gastroenterology. 2001;  121 668-677
  • 11 Perniola R, Falorni A, Clemente M G, Forini F, Accogli E, Lobreglio G. Organ-specific and non-organ-specific autoantibodies in children and young adults with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).  Eur J Endocrinol. 2000;  143 497-503
  • 12 Pitkanen J, Doucas V, Sternsdorf T, Nakajima T, Aratani S, Jensen K, Will H, Vahamurto P, Ollila J, Vihinen M, Scott H S, Antonarakis S E, Kudoh J, Shimizu N, Krohn K, Peterson P. The autoimmune regulator protein has transcriptional transactivating properties and interacts with common co-activator CBP.  J Biol Chem. 2000;  275 16802-16809
  • 13 Pitkanen J, Vahamurto P, Krohn K, Peterson P. Subcellular localization of the autoimmune regulator protein. Characterization of nuclear targeting and transcriptional activation domain.  J Biol Chem. 2001;  276 19597-19602
  • 14 Pyrsopoulos N T, Reddy K. Extrahepatic manifestations of chronic viral hepatitis.  Curr Gastroenterol Rep. 2001;  1 71-78
  • 15 Ramsey C, Winqvist O, Puhakka L, Halonen M, Moro A, Kampe O, Eskelin P, Pelto-Huikko M, Peltonen L. AIRE deficient mice develop multiple features of APECED phenotype and show altered immune response.  Hum Mol Genet. 2002;  11 397-409
  • 16 Roll U, Nuber A, Schroder A, Gerlach E, Janka H U, Ziegler A G. No association of antibodies to glutamic acid decarboxylase and diabetic complications in patients with IDDM.  Diabetes Care. 1995;  18 210-215
  • 17 Schenker M, Hummel M, Ferber K, Walter M, Keller E, Albert E D, Janka H U, Kastendiek C, Sorger M, Louwen F, Ziegler A G. Early expression and high prevalence of islet autoantibodies for DR3/4 heterozygous and DR4/4 homozygous offspring of parents with Type I diabetes: the German BABYDIAB study.  Diabetologia. 1999;  42 671-677
  • 18 Trepo C, Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis.  J Autoimmun. 2001;  16 269-274
  • 19 Vogel A, Liermann H, Harms A, Strassburg C P, Manns M P, Obermayer-Straub P. Autoimmune regulator AIRE: evidence for genetic differences between autoimmune hepatitis and hepatitis as part of the autoimmune polyglandular syndrome type 1.  Hepatology. 2001;  33 1047-1052
  • 20 Vogel A, Strassburg C, Obermayer-Straub P, Brabant G, Manns M. The genetic background of Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy and its autoimmune disease components.  J Mol Med. 2002;  80 201-211
  • 21 Ziegler A G, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study.  Diabetes. 1999;  48 460-468

1 These two authors contributed equally.

Dr. Martin Füchtenbusch

3rd. Med. Dept., Endocrinology, Diabetology & Gastroenterology, Academic Hospital München-Schwabing

Kölner Platz 1

80804 Munich

Germany

Phone: + 498930793114

Fax: + 4 98 93 08 17 33

Email: martin.fuechtenbusch@lrz.uni-muenchen.de